
Most fetal abnormalities occur in low-risk pregnancies. Screening techniques have been developed to help determine who in the low-risk group may actually be at high risk. Biochemical screening for chromosomal abnormalities and neutral tube defects have significantly increased their detection, but there is still considerable room for improvement.
Estriol, Genetic Diseases, Inborn, Chorionic Gonadotropin, Sensitivity and Specificity, Ultrasonography, Prenatal, Congenital Abnormalities, Pregnancy, Amniocentesis, Prevalence, Humans, Mass Screening, Female, alpha-Fetoproteins, Maternal Age
Estriol, Genetic Diseases, Inborn, Chorionic Gonadotropin, Sensitivity and Specificity, Ultrasonography, Prenatal, Congenital Abnormalities, Pregnancy, Amniocentesis, Prevalence, Humans, Mass Screening, Female, alpha-Fetoproteins, Maternal Age
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
